WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2000029406) NOVEL ISOXAZOLINE FIBRINOGEN RECEPTOR ANTAGONISTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/029406    International Application No.:    PCT/US1999/027356
Publication Date: 25.05.2000 International Filing Date: 18.11.1999
Chapter 2 Demand Filed:    29.05.2000    
IPC:
C07D 261/04 (2006.01), C07D 261/08 (2006.01), C07D 413/06 (2006.01), C07D 413/10 (2006.01), C07D 413/12 (2006.01), C07D 413/14 (2006.01), C07D 417/10 (2006.01), C07D 417/14 (2006.01), C07D 471/04 (2006.01), C07D 491/04 (2006.01), C07D 491/10 (2006.01)
Applicants: DU PONT PHARMACEUTICALS COMPANY [US/US]; Chestnut Run Plaza 974 Centre Road Wilmington, DE 19807 (US)
Inventors: SMALLHEER, Joanne, M.; (US).
WANG, Shuaige; (US).
JUDHAV, Prabhakar, Kondaji; (US)
Agent: LARSEN, Scott, K.; Du Pont Pharmaceuticals Company Legal Patent Records Center 1007 Market Street Wilmington, DE 19898 (US)
Priority Data:
60/108,835 18.11.1998 US
Title (EN) NOVEL ISOXAZOLINE FIBRINOGEN RECEPTOR ANTAGONISTS
(FR) NOUVEAUX ANTAGONISTES DU RECEPTEUR DE FIBRINOGENE A BASE D'ISOXAZOLINE
Abstract: front page image
(EN)This invention relates to novel isoxazolines and isoxazoles of formula (I) or a pharmaceutically acceptable salt or prodrug form thereof. The invention relates to novel isoxazolines which are useful as antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex, to pharmaceutical compositions containing such compounds, processes for preparing such compounds, and to methods of using these compounds, alone or in combination with other therapeutic agents, for the inhibition of platelet aggregation, as thrombolytics, and/or for the treatment of thromboembolic disorders.
(FR)L'invention concerne de nouveaux isoxazolines et isoxazoles correspondant à la formule (I) ou un sel pharmaceutiquement acceptable ou une forme de promédicament de ces composés. L'invention a pour objet de nouveaux isoxazolines qui peuvent servir d'antagonistes du complexe récepteur de fibrinogène IIb/IIIa glycoprotéines plaquettaires, des compositions pharmaceutiques contenant ces composés, des procédés pour préparer ces composés, isolément ou en combinaison avec d'autres agents thérapeutiques, qui sont utilisés pour inhiber l'agrégation plaquettaire, comme thrombolytiques et/ou dans le traitement de troubles thrombolytiques.
Designated States: AL, AU, BR, CA, CN, CZ, EE, HU, IL, IN, JP, KR, LT, LV, MK, MX, NO, NZ, PL, RO, SG, SI, SK, TR, UA, VN, ZA.
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE).
Publication Language: English (EN)
Filing Language: English (EN)